SCHEMBL2068396

SCHEMBL2068396

O=[N+]([O-])C=C1NCCN1CCNCc1ccc(Cl)nc1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.73
CHRNA1 P02708 2/20 0.66
CHRNA7 P36544 2/20 0.66
CHRNA3 P32297 1/20 0.66
ALDH1A1 P00352 2/20 0.50
CHRNB2 P17787 2/20 0.50
CHRNA4 P43681 2/20 0.50
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
CASP6 P55212 1/20 0.39
NAMPT P43490 1/20 0.37
SCN9A Q15858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL888508 0.85 SMN1; SMN2 (1.00) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
SCHEMBL6624321 0.85 SMN1; SMN2 (1.00) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
SCHEMBL888337 0.85 SMN1; SMN2 (1.00) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
Hydrochloric Acid SCHEMBL9069690 0.84 SMN1; SMN2 (0.98) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
Hydrochloric Acid SCHEMBL9069692 0.84 SMN1; SMN2 (0.98) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
SCHEMBL888580 0.80 CHRNA1 (1.00) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
SCHEMBL888464 0.80 CHRNA1 (1.00) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
SCHEMBL888465 0.80 CHRNA1 (1.00) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
Hydrochloric Acid SCHEMBL10483912 0.79 CHRNA1 (0.98) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1
Acetic Acid SCHEMBL10636735 0.78 SMN1; SMN2 (0.85) SMN1; SMN2CHRNA1CHRNA7CHRNA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977332-B2 Insecticidal N-(heteroarylalkyl)alkanediamine derivatives FMC CORPORATION (US) 2011-07-12 US disclosed
US-20110065710-A1 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives FMC CORPORATION 2011-03-17 US disclosed
EP-1689231-A4 INSECTICIDAL N-(HETEROARYLALKYL) ALKANEDIAMINE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2007-11-14 EP disclosed
EP-1689231-A2 INSECTICIDAL N-(HETEROARYLALKYL) ALKANEDIAMINE DERIVATIVES FMC CORPORATION (US) 2006-08-16 EP disclosed
WO-2005055715-A2 INSECTICIDAL N-(HETEROARYLALKYL) ALKANEDIAMINE DERIVATIVES FMC CORPORATION (US) 2005-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065710-A1 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives DDT, RABL6, ACHE SMN1; SMN2 2602/4885CHRNA1 932/4885CHRNA7 219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.